Dolutegravir
The chemical name of dolutegravir sodium is sodium (4R,12aS)-9-{[(2,4-difluorophenyl)methyl]carbamoyl}- 4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7- olate. Dolutegravir is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and children aged 12 years and older and weighing at least 40 kg.
Primary Characteristics
It is of Synthetic origin.
It belongs to Antiviral Agents pharmacological group on the basis of mechanism of action.
Molecular Weight: 441.36 · Solubility in Water: slightl soluble · Non-proprietary name: Dolutegravir.

Pharmacokinetics
Distribution: Dolutegravir has a volume of distribution is 17.4L. plasma protein binding is greater than 98.9%.
Elimination: it is metabolised via hepatic, plasma half-life is 14hrs, renal excretion is 53% by feces, 31% in urine.
Advertisement
Indications
Dolutegravir is primarily indicated in conditions like HIV infection in combination with other antiretroviral drugs.
Contraindications
None recorded.
Dosage
Dolutegravir's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 0 – 50 mg | — | — | PO | Patients infected with HIV-1 without suspected resistance to the integrase class |
| 50 mg | 50 mg | — | PO | patient infected with HIV-1 without suspected resistance to the integrase classwhen co-administered with some medicines (e.g. efavirenz, nevirapine, tipranavir/ritonavir, or rifampicin) i |
| 50 mg | 50 mg | — | PO | Patients infected with HIV-1 with resistance to the integrase class |
| Paediatric Dosage (20kg) | ||||
| 0 – 50 mg | — | — | PO | pediatric patients aged 12 years and older and weighing at least 40 kg |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Dolutegravir is known to cause more or less tolerable side effects which are usually transient. These include Headache, Insomnia.
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.6.5.2 — Antiretroviral drugs